American Heart Journal
Volume 148, Issue 5 , Pages 795-802 , November 2004

Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: Insights from GUSTO I Economics and Quality of Life substudy

  • Alejandro Barbagelata, MD

      Affiliations

    • Hospital Italiano, Buenos Aires, Argentina
    • ,
  • Robert M. Califf, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Elena B. Sgarbossa, MD

      Affiliations

    • Rush-Presbyterian-St. Luke's Medical Center, USA
    • ,
  • David Knight, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Daniel B. Mark, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Paul W. Armstrong, MD

      Affiliations

    • University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Marcelo Elizari, MD

      Affiliations

    • Hospital Ramos Mejia, Buenos Aires, Argentina
    • ,
  • Yochai Birnbaum, MD

      Affiliations

    • University of Texas Medical Branch, Galveston, Tex, USA
    • ,
  • Liliana R. Grinfeld, MD

      Affiliations

    • Hospital Italiano, Buenos Aires, Argentina
    • ,
  • E.Magnus Ohman, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Galen S. Wagner, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • Corresponding Author InformationReprint requests: Galen S. Wagner, MD, Duke University Medical Center, 2400 Pratt St, Rm 0306, Durham, NC 7705, USA.
    • ,
  • GUSTO-1 Investigators

Received 13 October 2003 ,Accepted 30 April 2004.

References 

  1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) . Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1986;1:397–401
  2. Wagner GS, Freye CJ, Palmeri ST, et al.  Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement. Circulation. 1982;65:342–347
  3. Ideker RE, Wagner GS, Ruth WK, et al.  Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol. 1982;49:1604–1614
  4. Sevilla DC, Wagner NB, White RD. Anatomic validation of electrocardiographic estimation of the size of acute or healed myocardial infarcts. Am J Cardiol 1990;65:1301–7
  5. Haisty WK, Pahlm O, Wagner NB, et al.  Performance of the automated complete Selvester QRS scoring system in normal subjects and patients with single and multiple myocardial infarctions. J Am Coll Cardiol. 1992;19:341–346
  6. Roark SF, White RD, Ideker RE, et al.  Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol. 1983;51:382–389
  7. Pahlm US, Chaitman BR, Rautaharju PM, et al.  Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. Am J Cardiol. 1998;81:809–815
  8. Palmeri ST, Harrison DG, Cobb FR, et al.  A QRS scoring system for assessing left ventricular function following myocardial infarction. N Engl J Med. 1982;306:4–9
  9. De Pace NL, Iskandrian AS, Hakki AH, et al.  Use of QRS scoring and thallium-201 scintigraphy to assess left ventricular function after myocardial infarction. Am J Cardiol. 1982;50:1262–1268
  10. Roubin GS, Shen WF, Kelly DT, et al.  The QRS scoring system for estimating myocardial infarct size (clinical, angiographic, and prognostic correlation). J Am Coll Cardiol. 1983;2:38–44
  11. Babbitt D, Marcus F, Wagner G, et al.  Comparison of QRS scoring system for estimating infarct size with radionuclide left ventriculography. Am Heart J. 1984;108:1426–1430
  12. Bounous E, Califf RM, Harrell FE, et al.  Prognostic value of the simplified Selvester QRS score in patients with coronary artery disease. J Am Coll Cardiol. 1988;11:35–41
  13. Jones MG, Anderson KM, Wilson PWF, et al.  Prognostic use of a QRS scoring system after hospital discharge for initial acute myocardial infarction in the Framingham cohort. Am J Cardiol. 1990;66:546–550
  14. Brunken R, Tillisch J, Schwaiger M, et al.  Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarction (evidence for persistence of viable tissue in some infarcts regions by positron emission tomography). Circulation. 1986;73:951–963
  15. Christian TF, Clements IP, Behrenbeck T. Limitations of the electrocardiogram in estimating infarct size after reperfusion therapy for acute myocardial infarction. Ann Intern Med. 1991;114:264–270
  16. Christian TF, Gibbons RJ, Clements IP, et al.  Estimates of myocardium at risk and collateral flow in acute myocardial infarction using electrocardiographic indexes with comparison to radionuclide and angiographic measures. J Am Coll Cardiol. 1995;26:383–393
  17. Marcassa C, Galli M, Paino A, et al.  Electrocardiographic evolution after Q-wave anterior myocardial infarction (correlation between QRS score and changes in left ventricular perfusion and function). J Nucl Cardiol. 2001;8:561–567
  18. Adler Y, Zafrir N, Ben-Gal T, et al.  Relation between evolutionary ST segment and T-wave direction and electrocardiographic prediction of myocardial infarct size and left ventricular function among patients UIT anterior wall Q-wave acute myocardial infarction who received reperfusion therapy. Am J Cardiol. 2000;85:927–933
  19. Bergovec M, Prpic H, Mihatov S, et al.  The value of the QRS scoring system in assessing regional and global left ventricular ejection fraction early after myocardial infarction. Eur Heart J. 1993;14:1102–1109
  20. De Sutter J, Van de Wiele C, Gheeraert P, et al.  The Selvester 32-Point QRS Score for Evaluation of Myocardial Infarct Size After Primary Coronary Angioplasty. Am J Cardiol. 1999;83:255–257
  21. Tateishi S, Abe S, Yamashita T, et al. Use of the QRS scoring system in the early estimation of myocardial infarct size following reperfusion. J Electrocardiol 1997;30:315-22
  22. Juergens CP, Fernandes C, Hasche ET, et al.  Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol. 1996;27:617–624
  23. The GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N.Engl J Med. 1993;329:673–682
  24. Mark DB, Naylor CD, Hlatky MA, et al.  Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med. 1994;331:1130–1135
  25. Hlatky MA, Boineau RE, Higginbotham MB, et al.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651–654
  26. Rose GA. Cardiovascular Survey Methods. (2nd ed). World Health Organization monograph series no. 56. Geneva: World Health Organization; 1982;
  27. The BARI Investigators . Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation. 1991;84(Suppl V):V.1, V.27
  28. French JK, Ramanathan K, Stewart J, et al.  A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction. Am Heart J. 2003;3:508
  29. Ray J. The TIMI risk score predicted mortality in patients with ST-elevation myocardial infarction. ACP J Club. 2002;136:76
  30. Raitt M, Maynard C, Wagner G, et al.  Appearance of abnormal Q waves early in the course of acute myocardial infarction (implications for efficacy of thrombolytic therapy). J Am Coll Cardiol. 1995;25:1084–1088
  31. Clemmensen P, Grande P, Saunamaki K, et al.  Effect of intravenous streptokinase on the relation between initial ST-predicted size and final QRS-estimated size of acute myocardial infarcts. J Am Coll Cardiol. 1990;16:1252–1257
  32. Clemmensen P, Ohman EM, Sevilla DC, et al.  Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction. Am J Cardiol. 1992;70:1391–1396
  33. McGuire KM, Healey J, Cibbs H, et al.  ECG evidence of limited myocardial infarction following coronary occlusion treated by early intravenous rTPA infusion. Eur Heart J. 1990;11:328–333
  34. Willems JL, Willems RJ, Bijness I, et al. Value of electrocardiographic scoring systems for the assessment of thrombolytic therapy in acute myocardial infarction. Eur Heart J 1991;12:378-88.
  35. Walamies MA, Siitonen SL, Koskinen MO. QRS score as an indicator of myocardial viability after thrombolytic therapy. J Electrocardiol. 1995;28:185–190
  36. Bosimini E, Giannuzzi P, Temporelli P, et al.  Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction. Results of the GISSI-3 Echo sub study. J Am Coll Cardiol. 2000;35:127–135
  37. Sawada SG, Allman K, Mizik O, et al.  Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol. 1994;23:92–98
  38. Altehofer C, Kaiser HJ, Dorr R, et al.  Fluorine-18-deoxiglucose PET for assessment of viable myocardium in perfusion defects in 99m Tc MIBI SPECT (a comparative study in patients with coronary artery disease). Eur J Nucl Med. 1992;19:334–342
  39. Hinohara T, Wagner NB, Cobb FR, et al.  An ischemic index from the electrocardiogram to select patients with low left ventricular ejection fraction for coronary artery bypass grafting. Am J Cardiol. 1988;61:288–291
  40. Shah BR, Velazquez E, Shaw LK, et al.  Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. Am Heart J. 2002;143:111–117
  41. Pudil R, Feimberg MS, Hod H, et al.  The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int J Cardiol. 2001;78:233–239
  42. Endt P, Montonen J, Makijarvi M, et al.  Identification of post-myocardial infarction patients with ventricular tachycardia by time-domain intra-QRS analysis of signal-averaged electrocardiogram and magnetocardiogram. Med Biol Eng Comput. 2000;38:659–665
  43. Lander P, Gomis P, Goyal R, et al.  Analysis of abnormal intra-QRS potentials. Improved predictive value for arrhythmic events with the signal-averaged electrocardiogram. Circulation. 1997;95:1386–1393

☆ Supported by grants from Bayer (New York, NY), Genentech, Inc. (South San Francisco, Calif), CIBA-Corning (Medfor, Mass), ICI Pharmaceuticals (Wilmington, Del), and Sanofi Pharmaceuticals (Paris, France).

PII: S0002-8703(04)00259-5

doi: 10.1016/j.ahj.2004.04.046

American Heart Journal
Volume 148, Issue 5 , Pages 795-802 , November 2004

Article Tools

* Image Usage & Resolution